Michael Hennigan, MD Endocrinology Open Now

Michael Hennigan, MD

Endocrinology, Diabetes & Metabolism, Internal Medicine
Gulf Breeze, FL 32561
Accepting New Patients Visit Website
(850) 807-9431

About Michael Hennigan MD

Michael Hennigan, MD is a doctor primarily located in Gulf Breeze, FL. He has 40 years of experience. His specialties include Endocrinology, Diabetes & Metabolism, Internal Medicine. He speaks English.


GoodEndos 41 Fairpoint Dr. Suite B Gulf Breeze, FL 32561


Michael Hennigan has the following 2 SPECIALTIES

Specialty Expertise

Michael Hennigan has the following 18 expertise

  • Hyperthyroidism
  • Lipid Metabolism Disorders
  • Diabetes (Types I & II)
  • Hypothyroidism
  • Hypopituitarism
  • Obesity
  • Cushing Disease
  • Diabetes
  • Acromegaly
  • High Blood Pressure (Hypertension)
  • Polycystic Ovary Syndrome (PCOS)
  • Addison Disease
  • Diabetes Mellitus, Type 1
  • Diabetes, Type 2
  • Osteoporosis
  • Fatigue
  • Hormones
  • Gland Issues


40 Years Experience

University Of Texas Health Science Center


University Of South Alabama College Of Medicine

Graduated in 1982

Michael Hennigan Accepts the Following Insurance

  • BCBS Blue Card PPO
  • BCBS FL Blue Choice
  • CIGNA Open Access Plus
  • Florida Blue BlueCare HMO
  • Florida Blue BlueOptions
  • Florida Blue BlueSelect
  • Florida Blue SimplyBlue
  • Humana Choice POS
  • Humana National POS
  • UHC Choice Plus POS
  • UHC Navigate HMO
  • UHC Options PPO

More about Michael Hennigan

Native of Gulf Breeze, FL. Dr. Michael Hennigan graduated from medical school at the University of South Alabama, then completed his residency at the University of Texas in Houston with rotations at MD Anderson. Serving 4 years with the US Public Health Service in North Carolina, he then moved to North Alabama where he and his wife raised 3 children and ran a successful practice for 20 years focusing on diabetes and lipid disorders. During that time, he also oversaw the Medicare program for the State of Alabama as a member of the Board of Directors of AQAF for 15 years. He was elected a Fellow of both the American College of Physicians (FACP) and the American College of Endocrinology (FACE) as a result of his demonstrated quality of care.

In 2011, he was hired by Novo Nordisk as a regional medical director for the Philadelphia area. was promoted to US Medical Director for Basil Insulin where he oversaw the FDA approval and launch of Tresiba (insulin degludec). In 2017, he returned to medical practice in NW Florida and how now again opened his own private practice as GoodEndos, LLC.

He has always loved hiking, taking his rescued Irish Wolfhound, Millie, alongside him. At nearly 4 feet tall and 125 lbs, she’s basically a house-horse!